Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis.

Gülçin Telli Dizman Jose María Aguado Mario Fernández-Ruiz

Published in: Expert review of anti-infective therapy (2022)

Infection is a frequent adverse event in patients receiving CAR T-cell therapy. Further research should address specific risk factors in this population.

Keyphrases

cell therapy
risk factors
stem cells
mesenchymal stem cells
emergency department
bone marrow